Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12298315
Systems and methods to identify and treat subjects at risk for obstetrical complications
granted -
US 12228582
Method and apparatus for testing near infrared-photoimmunotherapy treatment
granted -
US 12209142
SARS-CoV-2 epitope-targeted peptide immunostimulants
granted -
US 12201685
Methods of modulating immune responses with cationic lipid vaccine compositions
granted -
US 12186363
Compositions and methods for dengue virus chimeric constructions in vaccines
granted -
US 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
granted -
US 12152242
CRISPR therapy
granted -
US 12054519
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
granted -
US 12005115
Epstein-barr virus vaccines
granted -
US 11999747
Furoquinolinediones as inhibitors of TDP2
granted -
US 11959096
Methods for selective inhibition of pluripotent stem cells
granted -
US 11890340
Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
granted -
US 11878004
Method for inhibiting Zika virus infection
granted -
US 11865172
Materials and methods for respiratory disease control in canines
granted -
US 11802283
Oligonucleotide analogues targeting human LMNA
granted -
US 11684597
Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility
granted -
US 11672811
Materials and methods for suppressing and/or treating bone related diseases and symptoms
granted -
US 11654147
ALK2 inhibitors and methods for inhibiting BMP signaling
granted -
US 11542261
Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors
granted -
US 11497803
Modulation of replicative fitness by deoptimization of synonymous codons
granted -
US 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted -
US 11434268
Vascular endothelial growth factor antagonists
granted -
US 11371024
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
granted -
US 11325978
Compositions and methods for treating beta-globinopathies
granted